Cart
sales@molnova.com
Itacitinib
CAS No. 1334298-90-6
Itacitinib( INCB-039110 )
Catalog No. M11330 CAS No. 1334298-90-6
A potent and selective JAK1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 132 | In Stock |
|
| 2MG | 58 | In Stock |
|
| 5MG | 107 | In Stock |
|
| 10MG | 180 | In Stock |
|
| 25MG | 326 | In Stock |
|
| 50MG | 529 | In Stock |
|
| 100MG | 764 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameItacitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective JAK1 inhibitor.
-
DescriptionA potent and selective JAK1 inhibitor; shows >20 fold and >200 fold selectivity over JAK2 and JAK3 respectively; orally bioactive.Blood Cancer Phase 2 Clinical(In Vitro):Itacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2. Itacitinib is used in the research of myelofibrosis.
-
In VitroItacitinib (INCB039110) is a potent and selective inhibitor of JAK1, with >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2. Itacitinib is used in the research of myelofibrosis.
-
In Vivo——
-
SynonymsINCB-039110
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK1
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1334298-90-6
-
Formula Weight553.5142
-
Molecular FormulaC26H23F4N9O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESN#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(C5CCN(C(C6=C(F)C(C(F)(F)F)=NC=C6)=O)CC5)C1
-
Chemical Name3-Azetidineacetonitrile, 1-[1-[[3-fluoro-2-(trifluoromethyl)-4-pyridinyl]carbonyl]-4-piperidinyl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang Y, et al. Drug Metab Dispos. 2015 Apr;43(4):485-9.
2. Kim MK, et al. J Med Chem. 2015 Sep 24;58(18):7596-602.
3. Norman P. Expert Opin Investig Drugs. 2014 Aug;23(8):1067-77.
molnova catalog
related products
-
JAK-IN-35
JAK-IN-35 is a potent and efficacious dual JAK1/JAK3 inhibitor with IC50 of 0.9/1.9 nM.
-
Gingerenone A
A dual inhibitor of JAK2 and S6K1 pathways, selectively kills cancer cells while exhibiting minimal toxicity toward normal cells.
-
SHR0302
SHR0302 is a JAK inhibitor that binds JAK1 with stronger affinity than others (Selectivity for JAK1 is more than 10 times for JAK2, 77 times for JAK3, 420 times for Tyk2).
